Cell and gene therapies, biologics, and other temperature-sensitive products are moving out of trial settings and into everyday treatment, so more hospitals and treatment centers now sit at the end of a tightly controlled cold chain. Many of these products tolerate only a narrow temperature band between manufacturing and administration, and some are made from a single patient's own cells.

By the time one of these shipments reaches a care site, its packaging has usually been qualified. Engineers have tested the shipper against methods from the International Safe Transit Association (ISTA) and ASTM International and documented how long it holds temperature under defined conditions. Part of what gets qualified is a process: how the box is packed, how the coolant is prepared, how the monitor is set up, and how the package is handled. The test results apply only when that process is followed, and that includes the people who receive the shipment.

A Qualification Is Only as Reliable as Its Process

Qualification profiles are built around deliberately harsh, worst-case conditions, and no profile covers everything. A shipment can sit in the heat on an airport apron, run past its qualified duration because of a delay, or take enough rough handling to damage insulation or coolant. Those risks belong mostly to the shipper and carrier, and they're why shipments travel with temperature monitors.

Many failures, though, come down to steps that were defined and then not followed. A few examples:

· Orientation. Some shippers rely on coolant sitting on top of the payload. If the box is handled on its side when its qualification assumed it would stay upright, it may not perform as tested.

· Coolant preparation. Packout procedures specify how long gel packs or phase change bricks can sit out before loading. Some even require sitting out for prescribed durations. Deviating from that window, even by minutes, can change how the system performs.

· Monitor setup. A logger placed in the wrong spot, calibrated improperly, or programmed with the wrong start delay or recording interval may not capture what the product went through. An excursion can then go unrecorded.

Some of these steps happen at packout and some happen in transit. The last ones happen when the shipment arrives, and each can be undone by someone who doesn't know the step exists.

The Last Handoff Happens at the Receiving Site

One example shows how much depends on the receiving end. A drug product shipment specified for -15°C to -25°C and qualified with a phase change material system arrived at a facility where staff took the product out of the qualified packaging and repacked it with dry ice. The product went far below its specification. The investigation ruled out a packaging failure and traced the cause to inconsistent internal procedures and training. The qualified system was set aside before it could do its job.

Reusable shippers show the same pattern in a less obvious way. A reuse program depends on units coming back, and some are thrown away at the destination because the people unpacking them didn't know a return was expected. Every lost unit means one fewer qualified shipper for the next delivery.

Both problems show up at the receiving end, and both come down to what the receiving team was told. For each product they handle, staff should know:

· How it needs to be stored on arrival

· Whether repacking is ever permitted

· What to do with the temperature monitor

· Which components go back to the sender

Following the Process When an Excursion Is Flagged

Excursion response is a process too, with its own handoffs. For most temperature-sensitive shipments, the product owner, usually the manufacturer or sponsor, is alerted by the receiving site when a monitor records a deviation. The owner reconstructs what happened from logger data, timing, monitor placement, shipment history, and courier records while the product is held.

The release decision belongs to the product owner. They weigh how far and how long the product strayed against its stability data, then decide whether it can be used, needs more testing, or has to be destroyed. An excursion alone doesn't settle it, so a site that discards product on its own judgment can lose a dose that might have been released.

The site's job is to hold the product, report quickly, and keep what the investigation will need: the monitors, photos of the packout as it arrived, and notes on when the shipment came in and how it was handled.

What That Evidence Makes Possible

Those records let investigators work out whether the process broke down and where. They'll look at the packaging, how it was packed, the monitors, the courier, the weather, and the route. Comparing internal and external loggers is a useful first step. When both move together, environmental exposure is the likely cause. When a single internal logger stands out, placement or packout is the stronger suspect. Packout photos, calibration certificates, and tracking data help confirm which.

A formal corrective and preventive action (CAPA) plan follows. When the cause is procedural, that can mean rewriting instructions, retraining staff, or both. When the lane itself has changed, it can mean putting the qualification back through testing against the conditions the shipment saw.

Why It Matters at the Point of Care

With patient-specific or time-critical therapies, a lost shipment can mean collecting patient material again, restarting manufacturing, and delaying treatment for someone who may not have time to spare.

Qualification testing gives everyone in the chain a documented basis for confidence. That confidence holds only as long as each handoff follows the process the testing was built on, from the packout line at the manufacturer to the receiving room at the care site.

Robert Battista is Director, Engineering Solutions at Modality Solutions, a BlueRidge Life Sciences company and is the Cold Chain EngineeringTM partner for leading pharmaceutical and biopharmaceutical companies.